Skip to main content

Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease

Abstract

Purpose

This retrospective study aimed to determine the effects of diabetes on overall survival (OS) and cancer-specific survival (CSS) in patients with newly diagnosed colon cancers, with particular focus on the impact of diabetes on survival at each stage of colon cancer.

Methods

From January 1999 to January 2008, 2762 consecutive patients diagnosed with colon cancer in Taipei Veterans General Hospital were enrolled. The general characteristics as well as presence of diabetes prior to colon cancer diagnosis were identified. Cox proportional hazard analyses were used for prognostic factors determination; and survival was analyzed using the Kaplan–Meier method with log-rank test.

Results

A total of 469 patients (17%) had diabetes at diagnosis of colon cancer. Patients with diabetes had baseline characteristics comparable to those without diabetes with the exception that the patients with diabetes were older (>65 years). Diabetes significantly and negatively impacted OS and CSS in multivariate analyses. After adjusting for possible confounding factors, the prognostic impact of diabetes on OS and CSS was particularly significant in patients with stage II colon cancer.

Conclusions

Diabetes is a poor prognostic factor in patients with newly diagnosed colon cancer, and it may directly impact the tumor behavior of stage II disease. Further study is required to elucidate the underlying pathophysiologic mechanisms.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

References

  • Barone BB, Yeh HC, Snyder CF, Peairs KS, Stein KB, Derr RL, Wolff AC, Brancati FL (2008) Long-term all-cause mortality in cancer patients with preexisting diabetes mellitus: a systematic review and meta-analysis. JAMA 300:2754–2764. doi:10.1001/jama.2008.824

    CAS  Article  PubMed  Google Scholar 

  • Benson AB III, Schrag D, Somerfield MR, Cohen AM, Figueredo AT, Flynn PJ, Krzyzanowska MK, Maroun J, McAllister P, Van CE, Brouwers M, Charette M, Haller DG (2004) American Society of Clinical Oncology recommendations on adjuvant chemotherapy for stage II colon cancer. J Clin Oncol 22:3408–3419. doi:10.1200/JCO.2004.05.063

    Article  PubMed  Google Scholar 

  • Bezemer ID, Rinaldi S, Dossus L, Gils CH, Peeters PH, Noord PA, Bueno-de-Mesquita HB, Johnsen SP, Overvad K, Olsen A, Tjonneland A, Boeing H, Lahmann PH, Linseisen J, Nagel G, Allen N, Roddam A, Bingham S, Khaw KT, Kesse E, Tehard B, Clavel-Chapelon F, Agudo A, Ardanaz E, Quiros JR, Amiano P, Martinez-Garcia C, Tormo MJ, Pala V, Panico S, Vineis P, Palli D, Tumino R, Trichopoulou A, Baibas N, Zilis D, Hemon B, Norat T, Riboli E, Kaaks R (2005) C-peptide, IGF-I, sex-steroid hormones and adiposity: a cross-sectional study in healthy women within the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 16:561–572. doi:10.1007/s10552-004-7472-9

    Article  PubMed  Google Scholar 

  • Bureau of Health Promotion Department of Health, Taiwan (2002) Survey on the prevalence of hypertension, hyperglycemia and hyperlipidemia in Taiwan

  • Calle EE, Kaaks R (2004) Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 4:579–591. doi:10.1038/nrc1408

    CAS  Article  PubMed  Google Scholar 

  • Compton CC, Fielding LP, Burgart LJ, Conley B, Cooper HS, Hamilton SR, Hammond ME, Henson DE, Hutter RV, Nagle RB, Nielsen ML, Sargent DJ, Taylor CR, Welton M, Willett C (2000) Prognostic factors in colorectal cancer. College of American Pathologists Consensus Statement 1999. Arch Pathol Lab Med 124:979–994

    CAS  PubMed  Google Scholar 

  • Coughlin SS, Calle EE, Teras LR, Petrelli J, Thun MJ (2004) Diabetes mellitus as a predictor of cancer mortality in a large cohort of US adults. Am J Epidemiol 159:1160–1167. doi:10.1093/aje/kwh161

    Article  PubMed  Google Scholar 

  • Department of Health, Executive Yuan, Taiwan (2008) Health and vital statistics

  • El-Serag HB, Hampel H, Javadi F (2006) The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 4:369–380. doi:10.1016/j.cgh.2005.12.007

    Article  PubMed  Google Scholar 

  • Friberg E, Orsini N, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of endometrial cancer: a meta-analysis. Diabetologia 50:1365–1374. doi:10.1007/s00125-007-0681-5

    CAS  Article  PubMed  Google Scholar 

  • Frystyk J, Skjaerbaek C, Vestbo E, Fisker S, Orskov H (1999) Circulating levels of free insulin-like growth factors in obese subjects: the impact of type 2 diabetes. Diabetes Metab Res Rev 15:314–322. doi:10.1002/(SICI)1520-7560(199909/10)15:5<314:AID-DMRR56>3.0.CO;2-E

    CAS  Article  PubMed  Google Scholar 

  • Gill S, Loprinzi CL, Sargent DJ, Thome SD, Alberts SR, Haller DG, Benedetti J, Francini G, Shepherd LE, Francois Seitz J, Labianca R, Chen W, Cha SS, Heldebrant MP, Goldberg RM (2004) Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? J Clin Oncol 22:1797–1806. doi:10.1200/JCO.2004.09.059

    CAS  Article  PubMed  Google Scholar 

  • Goodwin PJ, Ennis M, Pritchard KI, Trudeau ME, Koo J, Madarnas Y, Hartwick W, Hoffman B, Hood N (2002) Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study. J Clin Oncol 20:42–51

    CAS  Article  PubMed  Google Scholar 

  • Greene FL, Page DL, Fleming ID (2002) AJCC cancer staging manual, 6th edn. Springer, New York

    Book  Google Scholar 

  • Gross CP, Guo Z, McAvay GJ, Allore HG, Young M, Tinetti ME (2006) Multimorbidity and survival in older persons with colorectal cancer. J Am Geriatr Soc 54:1898–1904. doi:10.1111/j.1532-5415.2006.00973.x

    Article  PubMed  Google Scholar 

  • Gunter MJ, Hoover DR, Yu H, Wassertheil-Smoller S, Rohan TE, Manson JE, Howard BV, Wylie-Rosett J, Anderson GL, Ho GY, Kaplan RC, Li J, Xue X, Harris TG, Burk RD, Strickler HD (2008) Insulin, insulin-like growth factor-I, endogenous estradiol, and risk of colorectal cancer in postmenopausal women. Cancer Res 68:329–337. doi:10.1158/0008-5472.CAN-07-2946

    CAS  Article  PubMed  Google Scholar 

  • Hammarsten J, Hogstedt B (2005) Hyperinsulinaemia: a prospective risk factor for lethal clinical prostate cancer. Eur J Cancer 41:2887–2895. doi:10.1016/j.ejca.2005.09.003

    CAS  Article  PubMed  Google Scholar 

  • Heald AH, Siddals KW, Fraser W, Taylor W, Kaushal K, Morris J, Young RJ, White A, Gibson JM (2002) Low circulating levels of insulin-like growth factor binding protein-1 (IGFBP-1) are closely associated with the presence of macrovascular disease and hypertension in type 2 diabetes. Diabetes 51:2629–2636. doi:10.2337/diabetes.51.8.2629

    CAS  Article  PubMed  Google Scholar 

  • Huxley R, nsary-Moghaddam A, de Berrington GA, Barzi F, Woodward M (2005) Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies. Br J Cancer 92:2076–2083. doi:10.1038/sj.bjc.6602619

    CAS  Article  PubMed  Google Scholar 

  • Jones RA, Campbell CI, Wood GA, Petrik JJ, Moorehead RA (2009) Reversibility and recurrence of IGF-IR-induced mammary tumors. Oncogene 28:2152–2162. doi:10.1038/onc.2009.79

    CAS  Article  PubMed  Google Scholar 

  • Larsson SC, Mantzoros CS, Wolk A (2007) Diabetes mellitus and risk of breast cancer: a meta-analysis. Int J Cancer 121:856–862. doi:10.1002/ijc.22717

    CAS  Article  PubMed  Google Scholar 

  • Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB III, Fuchs CS (2003) Impact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol 21:433–440. doi:10.1200/JCO.2003.07.125

    Article  PubMed  Google Scholar 

  • Neale RE, Doecke JD, Pandeya N, Sadhegi S, Green AC, Webb PM, Whiteman DC (2009) Does type 2 diabetes influence the risk of oesophageal adenocarcinoma? Br J Cancer 100:795–798. doi:10.1038/sj.bjc.6604908

    CAS  Article  PubMed  Google Scholar 

  • NIH Consensus Conference (1990) Adjuvant therapy for patients with colon and rectal cancer. JAMA 264:1444–1450

    Article  Google Scholar 

  • Park SM, Lim MK, Shin SA, Yun YH (2006) Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 24:5017–5024. doi:10.1200/JCO.2006.07.0243

    Article  PubMed  Google Scholar 

  • Polednak AP (2006) Comorbid diabetes mellitus and risk of death after diagnosis of colorectal cancer: a population-based study. Cancer Detect Prev 30:466–472. doi:10.1016/j.cdp.2006.07.003

    Article  PubMed  Google Scholar 

  • Rajpathak SN, Gunter MJ, Wylie-Rosett J, Ho GY, Kaplan RC, Muzumdar R, Rohan TE, Strickler HD (2009) The role of insulin-like growth factor-I and its binding proteins in glucose homeostasis and type 2 diabetes. Diabetes Metab Res Rev 25:3–12. doi:10.1002/dmrr.919

    CAS  Article  PubMed  Google Scholar 

  • Sandhu MS, Dunger DB, Giovannucci EL (2002) Insulin, insulin-like growth factor-I (IGF-I), IGF binding proteins, their biologic interactions, and colorectal cancer. J Natl Cancer Inst 94:972–980. doi:10.1093/jnci/94.13.972

    CAS  PubMed  Google Scholar 

  • Shonka NA, Anderson JR, Panwalkar AW, Reed EC, Steen PD, Ganti AK (2006) Effect of diabetes mellitus on the epidemiology and outcomes of colon cancer. Med Oncol 23:515–519. doi:10.1385/MO:23:4:515

    Article  PubMed  Google Scholar 

  • van de Poll-Franse LV, Houterman S, Janssen-Heijnen ML, Dercksen MW, Coebergh JW, Haak HR (2007) Less aggressive treatment and worse overall survival in cancer patients with diabetes: a large population based analysis. Int J Cancer 120:1986–1992. doi:10.1002/ijc.22532

    Article  PubMed  Google Scholar 

  • Will JC, Galuska DA, Vinicor F, Calle EE (1998) Colorectal cancer: another complication of diabetes mellitus? Am J Epidemiol 147:816–825

    CAS  PubMed  Google Scholar 

  • Wolpin BM, Meyerhardt JA, Chan AT, Ng K, Chan JA, Wu K, Pollak MN, Giovannucci EL, Fuchs CS (2009) Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer. J Clin Oncol 27:176–185. doi:10.1200/JCO.2008.17.9945

    Article  PubMed  Google Scholar 

Download references

Conflict of interest statement

The authors have no conflicts of interest to disclose.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Hao-Wei Teng.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Huang, YC., Lin, JK., Chen, WS. et al. Diabetes mellitus negatively impacts survival of patients with colon cancer, particularly in stage II disease. J Cancer Res Clin Oncol 137, 211–220 (2011). https://doi.org/10.1007/s00432-010-0879-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00432-010-0879-7

Keywords

  • Cancer-specific survival
  • Colon cancer
  • Diabetes mellitus
  • Stage II
  • Prognosis